For Research Use Only. Melanotan I is intended exclusively for in vitro and preclinical research. It is not approved for human use, is not a drug, and should never be administered to humans or to animals outside of an authorized research protocol.
What Is MC1R?
MC1R (melanocortin 1 receptor) is a class A G protein coupled receptor expressed primarily on melanocytes in the skin and on a subset of cells in other tissues. It is one of five members of the melanocortin receptor family (MC1R through MC5R), each of which binds different combinations of melanocortin peptides with different affinities and produces effects in different tissues.
The natural ligands of MC1R include alpha-melanocyte stimulating hormone (alpha-MSH) and adrenocorticotropic hormone (ACTH), both of which bind the receptor with high affinity and produce signaling through the canonical Gs alpha pathway. Beta-MSH and gamma-MSH also bind MC1R with somewhat lower affinity. The receptor has a natural antagonist in agouti signaling protein (ASIP), which competes with alpha-MSH for receptor binding and produces opposing effects on melanogenesis in research models.
Structurally, MC1R follows the typical class A GPCR architecture with seven transmembrane helices, an extracellular N-terminal region, and intracellular loops that interact with G proteins and downstream signaling components. The receptor has been characterized through structural studies and through extensive pharmacological characterization in research models, providing a substantial body of literature on its molecular function.
MC1R Signaling Pathways
The canonical signaling pathway downstream of MC1R activation involves coupling to the Gs alpha subunit, activation of adenylyl cyclase, increases in intracellular cyclic AMP, and activation of protein kinase A. This pathway is the primary route by which MC1R agonists like Melanotan I produce their effects in research models, and it has been characterized extensively in melanocyte cell culture systems and in animal models of pigmentation.
In melanocytes, the cyclic AMP elevation produced by MC1R activation leads to phosphorylation of CREB (cyclic AMP response element binding protein), which activates transcription of the MITF (microphthalmia-associated transcription factor) gene. MITF in turn activates expression of the genes encoding the melanogenic enzymes tyrosinase, TRP-1, and TRP-2, which together catalyze the production of melanin pigment from tyrosine.
This signaling cascade from MC1R activation to melanin production has been characterized extensively in research models and provides the molecular basis for the melanogenesis effects of Melanotan I. The cascade is conserved across mammalian species and represents one of the more well understood examples of GPCR-mediated regulation of gene expression in the cellular biology research literature.
For more on the melanogenesis effects produced by this signaling cascade, see our companion article on Melanotan I melanogenesis research and pigmentation studies.
MC1R Tissue Distribution
MC1R is expressed primarily on melanocytes in the skin, hair follicles, and other tissues containing melanin-producing cells. This tissue distribution makes the skin and hair the primary sites of MC1R action and the focus of most MC1R research.
Beyond melanocytes, MC1R is also expressed at lower levels on other cell types in research models, including some immune cells, endothelial cells, and various other tissues. These additional sites of expression have been studied for non-pigmentation effects of MC1R signaling, although the pigmentation effects through melanocyte MC1R remain the most extensively characterized in the published literature.
The dominant melanocyte expression of MC1R provides the basis for the pigmentation focus of Melanotan I research. The selective high expression of the receptor on melanocytes means that MC1R agonists like Melanotan I produce their primary research effects on pigmentation pathways in animal models, with secondary effects on other tissues being smaller and less prominent.
MC1R Polymorphisms and Pigmentation
One of the more interesting features of MC1R biology is the existence of multiple natural polymorphisms in the human population that affect receptor function. Loss of function polymorphisms in MC1R are associated with red hair, fair skin, and increased UV sensitivity in research populations, while wild-type or gain of function variants are associated with darker pigmentation and reduced UV sensitivity.
The polymorphism research on MC1R provides important context for understanding the receptor's role in pigmentation biology in research models. The natural variation in MC1R function across human populations directly demonstrates the receptor's central role in determining pigmentation phenotype, and this finding has been one of the major contributions of MC1R research to the broader pigmentation literature.
In animal research models, equivalent polymorphism studies have been conducted in mouse strains and other research species, providing comparative evidence on how MC1R variation affects pigmentation across species. These cross-species findings support the conclusion that MC1R is a fundamental regulator of melanogenesis throughout the mammalian lineage.
Melanotan I Binding at MC1R
Melanotan I binds MC1R with high affinity and selectivity, producing receptor activation and downstream signaling that mimics the effects of natural alpha-MSH in research models. The receptor binding properties of Melanotan I have been characterized in radioligand binding studies and in functional assays of receptor activation, with the published findings supporting binding affinity comparable to or greater than that of natural alpha-MSH at MC1R.
The selectivity of Melanotan I for MC1R over other melanocortin receptors is one of its defining features as a research tool. Unlike Melanotan II, which has broad activity at multiple melanocortin receptors, Melanotan I shows much higher selectivity for MC1R over MC3R, MC4R, and MC5R. This selectivity makes Melanotan I appropriate for research questions that require activation of MC1R specifically without confounding effects from other melanocortin receptors.
For more on the selectivity comparison with Melanotan II, see our companion article on Melanotan I vs Melanotan II: receptor selectivity in research.